Abstract
The deorphanization of the histamine H4 receptor (H4R) has led to a significant number of scientific publications and patent applications. Whereas some histamine H1, H2 and H3 receptor ligands were found to have significant affinity for H4R, several agonists and antagonists with high affinity for H4R and selectivity over the other histamine receptors were successfully designed and synthesized. Moreover, site-directed mutation studies on H4R have been performed and reveal detailed information on receptor-ligand interactions. This review will focus on the most important H4R ligand scaffolds and their structure-activity relationships and selectivity over other histamine receptors and specific H4R functional activity. Experimental data are used to construct and validate high resolution three-dimensional receptor-ligand models and, vice versa, in silico models are used to design and rationalize experimental studies to probe receptor-ligand interactions.
Keywords: Histamine H4, structure-activity relationships, site-directed mutations, receptor-ligand interactions, Isothioureas, quinoxaline fragment, compound 52, histamine-analogues, probe, Affinity, chemogenomical analyses, SAR studies
Current Topics in Medicinal Chemistry
Title: Molecular Determinants of Selective Agonist and Antagonist Binding to the Histamine H4 Receptor
Volume: 11 Issue: 6
Author(s): Enade P. Istyastono, Chris de Graaf, Iwan J.P. de Esch and Rob Leurs
Affiliation:
Keywords: Histamine H4, structure-activity relationships, site-directed mutations, receptor-ligand interactions, Isothioureas, quinoxaline fragment, compound 52, histamine-analogues, probe, Affinity, chemogenomical analyses, SAR studies
Abstract: The deorphanization of the histamine H4 receptor (H4R) has led to a significant number of scientific publications and patent applications. Whereas some histamine H1, H2 and H3 receptor ligands were found to have significant affinity for H4R, several agonists and antagonists with high affinity for H4R and selectivity over the other histamine receptors were successfully designed and synthesized. Moreover, site-directed mutation studies on H4R have been performed and reveal detailed information on receptor-ligand interactions. This review will focus on the most important H4R ligand scaffolds and their structure-activity relationships and selectivity over other histamine receptors and specific H4R functional activity. Experimental data are used to construct and validate high resolution three-dimensional receptor-ligand models and, vice versa, in silico models are used to design and rationalize experimental studies to probe receptor-ligand interactions.
Export Options
About this article
Cite this article as:
P. Istyastono Enade, de Graaf Chris, J.P. de Esch Iwan and Leurs Rob, Molecular Determinants of Selective Agonist and Antagonist Binding to the Histamine H4 Receptor, Current Topics in Medicinal Chemistry 2011; 11 (6) . https://dx.doi.org/10.2174/1568026611109060661
DOI https://dx.doi.org/10.2174/1568026611109060661 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of Pharmacotherapy for Attention Deficit Hyperactivity Disorder on Risk of Seizures in Pediatric Patients as Assessed in an Insurance Claims Database
Current Drug Safety Short, but Highly Concentrated, Direct Inhalations of Essential Oil Molecules Improve Poor Sleep Quality: A Natural History Controlled, Withingroup, Self-administration Field Pilot Study
Current Psychopharmacology Sedation in PACU: The Role of Propofol
Current Drug Targets Herbal Nanoformulations for Asthma Treatment
Current Pharmaceutical Design How Recent Patents Have Changed our Clinical Approach in Cardio-Thoracic Surgery
Recent Patents on Regenerative Medicine Pharmacological Targets for the Inhibition of Neurogenic Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents A Systematic Approach to Hypertensive Urgencies and Emergencies
Current Hypertension Reviews Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Recent Inventions in Powder Technology and Granular Science Incorporating Improved Drug Delivery
Recent Patents on Engineering Structural Insights into Chitinolytic Enzymes and Inhibition Mechanisms of Selective Inhibitors
Current Pharmaceutical Design Nanoparticles, Neurotoxicity and Neurodegenerative Diseases
Current Drug Metabolism Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins
Current Pharmaceutical Design Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions
Current Pharmaceutical Design Nitric Dioxide as Biologically Important Radical and its Role in Molecular Mechanism of Pancreatic Inflammation
Current Pharmaceutical Analysis Cancer Microbiome; Opportunities and Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry Management of Inflammatory Bowel Disease Using Stem Cell Therapy
Current Stem Cell Research & Therapy Poly(ADP-ribose)polymerase Inhibition - Where Now?
Current Medicinal Chemistry Carbon Monoxide, A Two-Face for the Protection of the Liver
Current Pharmaceutical Biotechnology